Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity

American Journal of Surgical Pathology

Volumn 21, Issue 2, 1997, Pages 242-248

  Koita, Hiroyuki ^a,d   Suzumiya, Junji ^b   Ohshima, Koichi ^b   Takeshita, Morishige ^b   Kimura, Nobuhiro ^b   Kikuchi, Masahiro ^b   Koono, Masashi ^c  

^a Nobeoka Prefectural Hospital   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

CD56; Lymphoblastic lymphoma; Nasal lymphoma; Natural killer cell

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; KILLER CELL; LYMPHATIC LEUKEMIA; MEDIASTINUM; MEMBRANE BINDING; NASOPHARYNX; PHENOTYPE; VIRUS INFECTION;

ANATOMY, CROSS-SECTIONAL; ANTIGENS, CD; BLOTTING, SOUTHERN; DNA NUCLEOTIDYLEXOTRANSFERASE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, LYMPHOBLASTIC; MALE; MEDIASTINAL NEOPLASMS; MICROSCOPY, ELECTRON; MIDDLE AGED; NOSE NEOPLASMS; PHENOTYPE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031049034     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199702000-00016     Document Type: Article

References (47)

1. Bernard A, Boumsell L, Reinherz EL, et al. Cell surface characterization of malignant T cells from lymphohlastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blond 1981;57:1105-10.
2. Borowitz MJ, Croker BP, Metzgar RS. Lymphoblastic with the phenotype of common acute lymphoblastic leukemia. Am J Clin Pathol 1983;79:387-91.
3. Campo E, Cardesa A, Alos L, et al. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses: an immunohistochemical study. Am J Clin Pathol 1991;96:184-90.
4. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-29.
5. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-46.
6. Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunologic phenotypes of lymphoblastic lymphoma. Cancer Res 1983;43:4486-90.
7. Fellbaum C, Hansmann M-L, Lennert K. Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchow Arch A Pathol Anal 1989;414:399-405.
8. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-30.
9. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988;9:291-3.
10. Ho FCS, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 1990;8:271-81.
11. Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984;2:413-26.
12. Jaffe ES, Chan JKC, Su I-J, et al. Report of the workshop on nasal and related extranodal angiocentric T/NK-cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11.
13. Kanavaros P, Lescs M-C, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-95.
14. Kawano S, Tatsumi E, Yoneda N, et al. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient. Hematol Oncol 1995;13:1-11.
15. Kem WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cells adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-7.
16. Kimura N, Takihara Y, Akiyoshi T, et al. Rearrangement of T-cell receptor 8 chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders. Cancer Res 1989;49:4488-92.
17. Kimura N, Takeshita M, Ohshima K, et al. Detection of Epstein-Barr virus DNA on sinonasal natural killer lymphoma. In: Proceedings of the XXV Congress of the International Society of Hematology, Cancun, Mexico, April 17-21, 1994.
18. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today 1992;13:392-5.
19. Lennert K, Feller AC. Histopathology of non-Htidgkin's lymphomas: based on the updated Kiel classification. Berlin: Springer-Verlag, 1992:244-51.
20. Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R. Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983;61:838-41.
21. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988;72:1674-81.
22. Medeiros LJ, Jaffe ES, Chen Y-Y, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol 1992;16:439-47.
23. Medeiros LJ. Surgical pathology of the lymph nodes and related organs. Jaffe ES, ed. Philadelphia: WB Saunders, 1994;306-12.
24. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-96.
25. Nathwani B, Diamond LW, Winberg CD, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1981; 48:2347-57.
26. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987;18:1257-62.
27. Ohshima K, Kikuchi M, Eguchi F, et al. Analysis of Epstein-Barr viral genomes in lymphoid malignancy using southern blotting, polymerase chain reaction and in situ hybridization. Virchow Arch B Cell Pathol 1990;59:383-90.
28. Ohshima K, Kikuchi M, Masuda Y, et al. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/ lymphoma: clinicopathological features. Cancer Res 1991;51: 4639-42.
29. Ohshima K, Takeo H, Kikuchi M, et al. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology 1994;25:569-79.
30. Orazi A, Cattoretti G, John K, Neiman RS. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol 1994;7:582-6.
31. Pallesen G, Hamilton-Dutoit SJ, Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliterations and Hodgkin's disease: two new developments in the EBV field. Adv Cancer Res 1993;62:179-239.
32. Peiper SC. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein-Barr virus in pathogenesis. Blood 1993;82:687-90.
33. Ritz J, Schmidt RE, Michon J, Hercend T, Schlossman SF. Characterization of functional surface structures on human natural killer cells. Adv Immunol 1988;42:181-211.
34. Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T/Natural killer cell progenitor in human fetal thymus. J Exp Med 1994;180:569-76.
35. Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros LJ. Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol 1992;16:300-5.
36. Sheibani K, Nathwani BN, Winberg CD, et al. Antigenically defined subgroups of lymphoblastic lymphoma: relationship to clinical presentation and biologic behavior. Cancer 1987;60:183-90.
37. Sheibani K, Winberg CD, Burke JS, et al. Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Leuk Res 1987;11:371-7.
38. Su I-J, Hsieh H-C, Lin K-H, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991;77:799-808.
39. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994;83:2255-60.
40. Suzumiya J, Takeshita M, Kimura N, Kikuchi M. TCR-CD56+CD2+ nasal lymphomas with membrane-localized CD3 positivity: are the CD3+ cells neoplastic or reactive? [Response to Letter]. Blood 1995;85:2994-6.
41. Swerdlow SH, Habeshaw JA, Richards MA, Rainey M, Murray LJ, Stansfeld AG. T lymphoblastic lymphoma with Leu-7 positive phenotype and unusual clinical course: a multiparameter study. Leuk Res 1985;9:167-73.
42. Takeshita M, Kimura N, Suzumiya J, et al. Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. Virchows Arch 1994;425:499-504.
43. Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986;67:474-8.
44. Wong KF, Chan JKC, Ng CS, et al. CD56(NHK 1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992;23:798-804.
45. Yamaguchi M, Ohno T, Oka K, et al. Discordant reaction of Leu4 and rabbit anti-human CD3ε in sinonasal 'T'-cell lymphoma. Int J Hematol 1993;59:25-30.
46. Yoda Y, Mori N, Oka K, Nakazawa M, Mukai R, Abe T. Intracytoplasmic localization of CD3 antigen in NKH1+ azurophilic granular T-lymphoblastic lymphoma cells. Acta Hematol Jpn 1989;52:740-8.
47. Yoshida T, Kikuchi M, Ooshima K, et al. Anti-human T-cell lymphotropic virus type I antibody-positive adult T-cell leukemia/ lymphoma with no monoclonal proviral DNA. Cancer 1989;64: 2515-24.